These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 26199172)

  • 21. Can Bladder and Prostate Sonomorphology Be Used for Detecting Bladder Outlet Obstruction in Patients With Symptomatic Benign Prostatic Hyperplasia?
    Ahmed AF; Bedewi M
    Urology; 2016 Dec; 98():126-131. PubMed ID: 27591808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation between intravesical prostatic protrusion and international prostate symptom score among Nigerian men with benign prostatic hyperplasia.
    Eze BU; Mbaeri TU; Oranusi KC; Abiahu JA; Nwofor AM; Orakwe JC; Mbonu OO
    Niger J Clin Pract; 2019 Apr; 22(4):454-459. PubMed ID: 30975947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Length and volume of intravesical prostatic protrusion closely correlated with bladder outflow obstruction in BPH patients].
    Zhang Y; Chen X; Wu ZJ; Zhang P; Zhang XD; Yang Y
    Zhonghua Nan Ke Xue; 2007 Nov; 13(11):1020-2. PubMed ID: 18077917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravesical protrusion of the prostate as a predictive method of bladder outlet obstruction.
    Reis LO; Barreiro GC; Baracat J; Prudente A; D'Ancona CA
    Int Braz J Urol; 2008; 34(5):627-33; discussion 634-7. PubMed ID: 18986567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive value of resistive index, detrusor wall thickness and ultrasound estimated bladder weight regarding the outcome after transurethral prostatectomy for patients with lower urinary tract symptoms suggestive of benign prostatic obstruction.
    Huang T; Qi J; Yu YJ; Xu D; Jiao Y; Kang J; Chen YQ; Zhu YK
    Int J Urol; 2012 Apr; 19(4):343-50. PubMed ID: 22220830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urodynamic effects of dutasteride add-on therapy to alpha-adrenergic antagonist for patients with benign prostatic enlargement: prospective pressure-flow study.
    Wada N; Kita M; Hashizume K; Matsumoto S; Kakizaki H
    Neurourol Urodyn; 2013 Nov; 32(8):1123-7. PubMed ID: 23861329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urinary bladder characteristics via ultrasound as predictors of acute urinary retention in men with benign prostatic hyperplasia.
    Ho CC; Ngoo KS; Hamzaini AH; Rizal AM; Zulkifli MZ
    Clin Ter; 2014; 165(2):75-81. PubMed ID: 24770808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of intravesical prostatic protrusion with bladder outlet obstruction.
    Chia SJ; Heng CT; Chan SP; Foo KT
    BJU Int; 2003 Mar; 91(4):371-4. PubMed ID: 12603417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravesical prostatic protrusion is a risk factor for bladder stone in patients with benign prostatic hyperplasia.
    Kim JW; Oh MM; Park HS; Cheon J; Lee JG; Kim JJ; Moon du G
    Urology; 2014 Nov; 84(5):1026-9. PubMed ID: 25214201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of intravesical prostatic protrusion (IPP) in the evaluation and treatment of bladder outlet obstruction (BOO).
    Kuo TL; Teo JS; Foo KT
    Neurourol Urodyn; 2016 Apr; 35(4):535-7. PubMed ID: 25727301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between the neutrophil-to-lymphocyte ratio and intravesical prostatic protrusion in men with benign prostatic hyperplasia.
    Chung MS; Yang YJ; Lee SH; Yoon BI
    Low Urin Tract Symptoms; 2020 Jan; 12(1):62-67. PubMed ID: 31523936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravesical prostatic protrusion predicts clinical progression of benign prostatic enlargement in patients receiving medical treatment.
    Lee LS; Sim HG; Lim KB; Wang D; Foo KT
    Int J Urol; 2010 Jan; 17(1):69-74. PubMed ID: 19919641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationships between Prostatic Volume and Intravesical Prostatic Protrusion on Transabdominal Ultrasound and Benign Prostatic Obstruction in Patients with Lower Urinary Tract Symptoms.
    Wang D; Huang H; Law YM; Foo KT
    Ann Acad Med Singap; 2015 Feb; 44(2):60-5. PubMed ID: 25797818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thickness-to-Height Ratio of Intravesical Prostatic Protrusion Predicts the Clinical Outcome and Morbidity of Prostatic Artery Embolization for Benign Prostatic Hyperplasia.
    Yu SCH; Cho CCM; Hung EHY; Zou J; Yuen BTY; Shi L; Chiu PKF; Yee SCH; Ng ACF
    J Vasc Interv Radiol; 2019 Nov; 30(11):1807-1816. PubMed ID: 31587946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anatomic configuration of prostate obtained by noninvasive ultrasonography can predict clinical voiding parameters for determining BOO in men with LUTS.
    Doo CK; Uh HS
    Urology; 2009 Feb; 73(2):232-6. PubMed ID: 19038424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of persistent storage symptoms after transurethral resection of the prostate in patients with benign prostatic enlargement.
    Choi H; Kim JH; Shim JS; Park JY; Kang SH; Moon du G; Cheon J; Lee JG; Kim JJ; Bae JH
    Urol Int; 2014; 93(4):425-30. PubMed ID: 25300422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improvement of Overactive Bladder Symptoms and Bladder Ischemia with Dutasteride in Patients with Benign Prostatic Enlargement.
    Wada N; Matsumoto S; Kita M; Hashizume K; Kakizaki H
    Low Urin Tract Symptoms; 2015 Jan; 7(1):37-41. PubMed ID: 26663650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between metabolic syndrome and intravesical prostatic protrusion in patients with benign prostatic enlargement and lower urinary tract symptoms (MIPS Study).
    Russo GI; Regis F; Spatafora P; Frizzi J; Urzì D; Cimino S; Serni S; Carini M; Gacci M; Morgia G
    BJU Int; 2018 May; 121(5):799-804. PubMed ID: 28872764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for failure of long-term dutasteride add-on treatment to alpha-adrenergic antagonist for patients with lower urinary tract symptoms and benign prostatic enlargement.
    Wada N; Abe N; Miyauchi K; Ishikawa M; Makino S; Kakizaki H
    Int Urol Nephrol; 2022 Jan; 54(1):31-36. PubMed ID: 34767140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of intravesical prostatic protrusion in the evaluation of overactive bladder in male patients with LUTS.
    Tsai CH; Lee WC; Shen YC; Wang HJ; Chuang YC
    Int Urol Nephrol; 2020 May; 52(5):815-820. PubMed ID: 31897874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.